Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Teijin Ltd (3401) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011956
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products, pharmaceuticals, medical devices and water purification systems. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, infectious and other diseases. Teijin operates facilities in America, Europe, Asia and Japan. The company sells its products in Asia, America, and Europe. Teijin is headquartered in Osaka, Japan.

Teijin Ltd (3401) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Teijin Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Teijin Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Teijin Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Teijin Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Teijin Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Teijin Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Teijin Enters into Licensing Agreement with Nativis 10
Teijin Pharma Enters into Distribution Agreement with SRETT 11
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 12
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 13
Debt Offering 14
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 14
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 15
Acquisition 16
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 16
Teijin Acquires 50% Stake in Nakashima Medical 17
Teijin Ltd – Key Competitors 18
Teijin Ltd – Key Employees 19
Teijin Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 22
Recent Developments 23
Financial Announcements 23
May 09, 2017: Teijin Reports Revenue Of JPY741.3 Billion In Fiscal 2017 23
Feb 06, 2017: TEIJIN:Consolidated Financial Statements For Nine Months Ended December 31 2016 24
Product News 30
01/29/2016: Teijin Pharma to Start Rental Service for SLEEPMATE 10 Continuous Positive Airway Pressure Device 30
Other Significant Developments 31
Sep 05, 2016: Teijin Publishes Integrated Report 2016 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Teijin Ltd, Medical Equipment, Key Facts, 2017 2
Teijin Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Teijin Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Teijin Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Teijin Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Teijin Ltd, Deals By Market, 2011 to YTD 2017 8
Teijin Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Teijin Enters into Licensing Agreement with Nativis 10
Teijin Pharma Enters into Distribution Agreement with SRETT 11
Teijin Pharma Enters into Co-Marketing Agreement with Taisho Toyama Pharma 12
Teijin Pharma Enters into Co-Development Agreement with Kaketsuken 13
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2018 14
Teijin Raises USD169.42 Million in Public Offering of Bonds Due 2021 15
Teijin to Acquire 86% of Implantable Medical Product Company of Takiron 16
Teijin Acquires 50% Stake in Nakashima Medical 17
Teijin Ltd, Key Competitors 18
Teijin Ltd, Key Employees 19
Teijin Ltd, Other Locations 20
Teijin Ltd, Subsidiaries 20
Teijin Ltd, Joint Venture 22

★海外企業調査レポート[Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • AirAsia Berhad:戦略・SWOT・企業財務分析
    AirAsia Berhad - Strategy, SWOT and Corporate Finance Report Summary AirAsia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CSG Systems International Inc (CSGS):企業の財務・戦略的SWOT分析
    CSG Systems International Inc (CSGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • OCI Co Ltd (010060):電力:M&Aディール及び事業提携情報
    Summary OCI Co Ltd (OCI) is a green energy and chemical company. It manufactures and sells a wide range of inorganic chemicals, coal and petrochemicals, and fine chemicals. The company’s product portfolio includes toluene di-isocyanate (TDI), hydrogen peroxide, carbon black, pitch, sodium percarbona …
  • Deoleo, S.A.:企業の戦略・SWOT・財務情報
    Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report Summary Deoleo, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Navigo Proteins GmbH (Navigo Proteins), formerly Scil Proteins GmbH, a subsidiary of UV-Cap GmbH & Co KG, is a protein engineering company that offers generation and optimization of proteins for therapeutic and non-therapeutics. The company provides microbial production of recombinant protei …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Astaldi Spa
    Astaldi Spa - Strategy, SWOT and Corporate Finance Report Summary Astaldi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • IXYS Corporation (IXYS):企業の財務・戦略的SWOT分析
    IXYS Corporation (IXYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies into new medicines. The center offers target validation, screen …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Carlisle Coatings & Waterproofing Inc:企業の戦略的SWOT分析
    Carlisle Coatings & Waterproofing Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …
  • CooperVision Inc-医療機器分野:企業M&A・提携分析
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Boone Electric Cooperative:企業の戦略的SWOT分析
    Boone Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • HMicro Inc-医療機器分野:企業M&A・提携分析
    Summary HMicro Inc (HMicro) is a medical device company that offers wireless sensor solutions. The company offers REACH wireless module, a wireless silicon platform that offers fully disposable and wearable wireless sensor patches for a range of professional clinical procedures in hospitals, clinics …
  • Wacker Chemie AG (WCH):企業の財務・戦略的SWOT分析
    Wacker Chemie AG (WCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Qisda Corporation
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Southwest Gas Holdings, Inc.:企業の戦略・SWOT・財務分析
    Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Southwest Gas Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆